These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24431415)

  • 1. Phenytoin dosing and serum concentrations in paediatric patients requiring 20 mg/kg intravenous loading.
    Piper JD; Hawcutt DB; Verghese GK; Spinty S; Newland P; Appleton R
    Arch Dis Child; 2014 Jun; 99(6):585-6. PubMed ID: 24431415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum phenytoin concentrations in paediatric patients following intravenous loading.
    Hawcutt DB; Sampath S; Timmis A; Newland V; Newland P; Appleton R
    Arch Dis Child; 2011 Sep; 96(9):883-4. PubMed ID: 21596726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, Tolerability and Serum Phenytoin Levels after Intravenous Fosphenytoin Loading Dose in Children with Status Epilepticus.
    Srivastava K; Bhartiya S; Gavli V; Patil R; Rajadhyaksha S
    Indian Pediatr; 2020 Mar; 57(3):218-221. PubMed ID: 32198860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software.
    Batchelor H; Appleton R; Hawcutt DB
    Seizure; 2015 Dec; 33():8-12. PubMed ID: 26517379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
    Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of IV fosphenytoin pharmacokinetics to determine the loading dose for a clinical trial of canine status epilepticus.
    Coles LD; Leppik IE; Patterson EE; Rivers Z; Mishra U; Cloyd JC
    Epilepsia; 2015 Jun; 56(6):888-94. PubMed ID: 25952988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Intravenous Phenytoin and Fosphenytoin Loading Doses: Influence of Obesity and Sex.
    DasGupta R; Alaniz C; Burghardt D
    Ann Pharmacother; 2019 May; 53(5):458-463. PubMed ID: 30522345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
    Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
    Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effective dose schedule for phenytoin treatment of status epilepticus in infancy and childhood.
    Albani M
    Neuropadiatrie; 1977 Aug; 8(3):286-92. PubMed ID: 578299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a phenytoin loading dose program in the emergency department.
    Brancaccio A; Giuliano C; McNorton K; Delgado G
    Am J Health Syst Pharm; 2014 Nov; 71(21):1862-9. PubMed ID: 25320136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Body Habitus on Phenytoin Levels Following Fosphenytoin Loading Dose in Pediatric Patients.
    Messinger MM; Moffett BS; Wilfong A
    Ther Drug Monit; 2015 Dec; 37(6):772-5. PubMed ID: 26402424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of intravenous phenytoin in children.
    Koren G; Brand N; Halkin H; Dany S; Shahar E; Barzilay Z
    Pediatr Pharmacol (New York); 1984; 4(1):31-8. PubMed ID: 6739185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
    Fischer JH; Patel TV; Fischer PA
    Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of a continuous intravenous infusion of valproic acid in pediatric patients.
    Taylor LM; Farzam F; Cook AM; Lewis DA; Baumann RJ; Kuhn RJ
    Pharmacotherapy; 2007 Apr; 27(4):519-25. PubMed ID: 17381378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, Tolerability, and Pharmacokinetics of Fosphenytoin Loading in Patients With Subarachnoid Hemorrhage.
    Kim DW; Kim TE; Ji M; Chun YI
    Clin Neuropharmacol; 2015; 38(6):248-51. PubMed ID: 26536021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial.
    Sreenath TG; Gupta P; Sharma KK; Krishnamurthy S
    Eur J Paediatr Neurol; 2010 Mar; 14(2):162-8. PubMed ID: 19297221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding.
    Kitchen D; Smith D
    Seizure; 2001 Jun; 10(4):265-8. PubMed ID: 11466022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
    Wolf GK; McClain CD; Zurakowski D; Dodson B; McManus ML
    Pediatr Crit Care Med; 2006 Sep; 7(5):434-9; quiz 440. PubMed ID: 16885794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriateness of intravenous loading dose of phenytoin treatment in Srinagarind Hospital.
    Tiamkao S; Chitravas N; Jitpimolmard S; Sawanyawisuth K
    J Med Assoc Thai; 2005 Nov; 88(11):1638-41. PubMed ID: 16471113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers.
    Tanaka J; Kasai H; Shimizu K; Shimasaki S; Kumagai Y
    Eur J Clin Pharmacol; 2013 Mar; 69(3):489-97. PubMed ID: 22918614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.